These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Lipid nanoparticles for short interfering RNA delivery. Leung AK; Tam YY; Cullis PR Adv Genet; 2014; 88():71-110. PubMed ID: 25409604 [TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Witzigmann D; Kulkarni JA; Leung J; Chen S; Cullis PR; van der Meel R Adv Drug Deliv Rev; 2020; 159():344-363. PubMed ID: 32622021 [TBL] [Abstract][Full Text] [Related]
11. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Yonezawa S; Koide H; Asai T Adv Drug Deliv Rev; 2020; 154-155():64-78. PubMed ID: 32768564 [TBL] [Abstract][Full Text] [Related]
13. Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery. Sun D; Lu ZR Pharm Res; 2023 Jan; 40(1):27-46. PubMed ID: 36600047 [TBL] [Abstract][Full Text] [Related]
14. Development and applications of mRNA treatment based on lipid nanoparticles. Wang Z; Ma W; Fu X; Qi Y; Zhao Y; Zhang S Biotechnol Adv; 2023; 65():108130. PubMed ID: 36933868 [TBL] [Abstract][Full Text] [Related]
15. Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction. Vhora I; Lalani R; Bhatt P; Patil S; Misra A Int J Pharm; 2019 May; 563():324-336. PubMed ID: 30954673 [TBL] [Abstract][Full Text] [Related]
16. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441 [TBL] [Abstract][Full Text] [Related]
17. Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities. Simonsen JB J Control Release; 2024 Jun; 370():763-772. PubMed ID: 38621638 [TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms. de Jesus MB; Zuhorn IS J Control Release; 2015 Mar; 201():1-13. PubMed ID: 25578828 [TBL] [Abstract][Full Text] [Related]
19. Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids. Mendonça MCP; Kont A; Kowalski PS; O'Driscoll CM Drug Discov Today; 2023 Mar; 28(3):103505. PubMed ID: 36708760 [TBL] [Abstract][Full Text] [Related]
20. Lipid-based nanoparticle formulations for small molecules and RNA drugs. Ickenstein LM; Garidel P Expert Opin Drug Deliv; 2019 Nov; 16(11):1205-1226. PubMed ID: 31530041 [No Abstract] [Full Text] [Related] [Next] [New Search]